Gene variations in the cholecystokinin system in patients with panic disorder

Psychiatric Genetics

Volumn 20, Issue 2, 2010, Pages 59-64

  Koefoed, Pernille ^a,b,c   Woldbye, David P ^a,c   Hansen, Thomas O ^b   Hansen, Elsebeth S ^c,d   Knudsen, Gitte M ^a   Bolwig, Tom G ^c   Rehfeld, Jens F ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Department of Clinical Biochemistry ^*  (Denmark)

^c Centre of Psychiatry   (Denmark)

^d Oringe   (Denmark)

Author keywords

Case control study; Exon trapping; Panic disorder; Sequency

Indexed keywords

CHOLECYSTOKININ;

ADULT; ALTERNATIVE RNA SPLICING; ARTICLE; EXON; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PANIC; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION;

ALTERNATIVE SPLICING; CHOLECYSTOKININ; EXONS; FEMALE; GENETIC VARIATION; HUMANS; INTRONS; MALE; PANIC DISORDER; PROMOTER REGIONS, GENETIC; RECEPTORS, CHOLECYSTOKININ;

EID: 77953739153     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e32833511a8     Document Type: Article

References (43)

1. Binkley K, King N, Poonai N, Seeman P, Ulpian C, Kennedy J (2001). Idiopathic environmental intolerance: Increased prevalence of panic disorder-associated cholecystokinin B receptor allele 7. J Allergy Clin Immunol 107:887-890.
2. Bradwejn J, Koszycki D, Shriqui C (1991). Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings. Arch Gen Psychiat 48:603-610.
3. Chakravarti A (1999). Population genetics - making sense out of sequence. Nat Genet 21 (Suppl):56-60.
4. Church DM, Stotler CJ, Rutter JL, Murrell JR, Trofatter JA, Buckler AJ (1994). Isolation of genes from complex sources of mammalian genomic DNA using exon amplification. Nat Genet 6:98-105.
5. DeMotigny C (1989). Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers: Preliminary findings. Arch Gen Psychiat 46:511-517.
6. Eser D, Schü le C, Baghai T, Floesser A, Krebs-Brown A, Enunwa M, et al. (2007). Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study. Psychopharmacology (Berl) 192:479-487.
7. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. (2002). The structure of haplotype blocks in the human genome. Science 296:2225-2229.
8. Goldstein DB, Chikhi L (2002). Human migrations and population structure: what we know and why it matters. Annu Rev Genomics Hum Genet 3:129-152.
9. Gratacòs M, Costas J, de Cid R, Bayé s M, Gonzá lez JR, Baca-García E, et al. (2009). Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment. Am J Med Genet: Part B 150B:808-816.
10. Hamilton SP, Slager SL, Helleby L, Heiman GA, Klein DF, Hodge SE, et al. (2001). No association or linkage between polymorphisms in the genes encoding cholecystokinin and the cholecystokinin B receptor and panic disorder. Mol Psychiatry 6:59-65.
11. Hansen TVO, Rehfeld JF, Nielsen FC (2000). Function of the C-36 to T polymorphism in the human cholecystokinin gene promoter. Mol Psychiatry 5:443-447.
12. Hansen TV, Bisgaard ML, Jønson L, Albrechtsen A, Filtenborg-Barnkob B,Eiberg H, et al. (2008). Novel de novo BRCA2 mutation in a patient with a family history of breast cancer. BMC Med Genet 9:58.
13. Hattori E, Yamada K, Toyota T, Yoshitsugu K, Toru M, Shibuya H et al. (2001). Association studies of the CT repeat polymorphism in the 50-upstream region of the cholecystokinin B receptor gene with panic disorder and schizophrenia in Japanese subjects. Am J Med Genet: Part B 105B:779-782.
14. Haugbol S, Pinborg LH, Arfan HM, Frokjaer VM, Madsen J, Dyrby TB, et al. (2007). Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach. Eur J Nucl Med Mol Imaging 34:910-915.
15. Hilke S, Hö kfelt T, Darwish M, Theodorsson E (2007). Cholecystokinin levels in the rat brain during the estrous cycle. Brain Res 1144:70-73.
16. Hö sing VG, Schirmacher A, Kuhlenbäumer G, Freitag C, Sand P, Schlesiger C et al. (2004). Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder. J Neural Transm 68 (Suppl):147-156.
17. Ise K, Akiyoshi J, Horinouchi Y, Tsutsumi T, Isogawa K, Nagayama H (2003). Association between the CCK-A receptor gene and panic disorder. Am J Med Genet: Part B 118B:29-31.
18. Kato T, Wang ZW, Zoega T, Crowe RR (1996). Missense mutation of the cholecystokinin B receptor gene: Lack of association with panic disorder. Am J Med Genet 67:401-405.
19. Kennedy JL, Bradwejn J, Koszycki D, King N, Crowe R, Vincent J, et al. (1999). Investigation of cholecystokinin system genes in panic disorder. Mol Psychiatry 4:284-285.
20. Kessing LV, Jørgensen OS (1999). Apolipoprotein E-epsilon 4 frequency in affective disorder. Biol Psychiatry 45:430-434.
21. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. (1994). Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States. Arch Gen Psychiatry 51:8-19.
22. Koefoed P, Hansen TvO, Woldbye DPD, Werge T, Mors M, Hansen T, et al. (2009). An intron 1 polymorphism in the CCK-A receptor gene associated with schizophrenia in males. Acta Psychiatr Scand 120:281-287.
23. Marchal-Victorion S, Vionnet N, Escrieut C, Dematos F, Dina C, Dufresne M, et al. (2002). Genetic, pharmacological and functional analysis of cholecystokinin- 1 and cholecystokinin-2 receptor polymorphism in type 2 diabetes and obese patients. Pharmacogenetics 12:23-30.
24. Maron E, Nikopensius T, Kõ ks S, Altmäe S, Heinaste E, Vibrit K, et al. (2005). Association study of 90 candidate gene polymorphisms in panic disorder. Psychiatr Genet 15:17-24. (Pubitemid 40411566)
25. Maron E, Kallassalu K, Tammiste A, Kolde R, Vilo J, Tõ ru I, et al. (2008). Peripheral gene expression profiling of CCK-4-induced panic in healthy subjects. Am J Med Genet: Part B [Epub ahead of print]
26. McClellan JM, Susser E, King M-C (2007). Schizophrenia: A common disease caused by multiple rare alleles. Br J Psychiatry 190:194-199.
27. Mellerup E, Bennike B, Bolwig T, Dam H, Hasholt L, Jorgensen MB, et al. (2001). Platelet serotonin transporters and the transporter gene in control subjects, unipolar patients and bipolar patients. Acta Psychiatr Scand 103:229-233.
28. Micevych P, Ulibarri C (1992). Development of the limbic-hypothalamic cholecystokinin circuit: A model of sexual differentiation. Dev Neurosci 14:11-34.
29. Micevych P, Eckersell CB, Holland KL, Smith A (1996). Induction of CCK mRNA levels in the limbic-hypothalamic circuit: Time course and site-specific effects of estrogen. J Neurobiol 30:465-479.
30. Minato T, Tochigi M, Kato N, Sasaki T (2007). Association study between the cholecystokinin A receptor gene and schizophrenia in the Japanese population. Psychiatr Genet 17:117-119. (Pubitemid 46586684)
31. Miyasaka K, Yoshida Y, Matsushita S, Higuchi S, Shirakawa O, Shimokata H, et al. (2004). Association of cholecystokinin-A receptor gene polymophisms and panic disorder in Japanese. Am J Med Genet: Part B 127B:78-80. (Pubitemid 38542318)
32. Ober C, Loisel DA, Gilad Y (2008). Sex-specific genetic architecture of human disease. Nat Rev Genet 9:911-922.
33. Popper P, Priest CA, Micevych P (1996). Regulation of cholecystokinin receptors in the ventromedial nucleus of the hypothalamus: Sex steroid hormone effects. Brain Res 712:335-339.
34. Rehfeld JF (1992). Cholecystokinin and anxiety, an overview. In: Dourish CT, Cooper SJ, Iversen SD, Iversen LL, editors. Multiple cholecystokinin receptors in the CNS. Oxford, New York: Oxford University Press; pp. 117-120.
35. Rehfeld JF (2000). Cholecystokinin and panic disorders: Three unsettled questions. Regul Peptides 39:79-83.
36. Sanjuan J, Toirac I, Gonzá lez JC, Leal C, Moltó MD, Ná jera C, et al. (2004). A possible association between the CCK-AR gene and persistent auditory hallucinations in schizophrenia. Eur Psychiatry 19:349-353.
37. Smoller JW, Gardner-Schuster E, Covino J (2008). The genetic basis of panic and phobic anxiety disorders. Am J Med Genet: Part C 148C:118-126.
38. Tachikawa H, Harada S, Kawanishi Y, Okubo T, Shiraishi H (2000). Novel polymorphisms of the human cholecystokinin A receptor gene: An association analysis with schizophrenia. Am J Med Genet: Part B 96B:141-145. (Pubitemid 30180851)
39. Toirac I, Sanjuán J, Aguilar EJ, Gonzá lez JC, Artigas F, Rivero O, et al. (2007). Association between CCK-AR gene and schizophrenia with auditory hallucinations. Psychiatr Genet 17:47-53.
40. Wang Z, Valdes J, Noyes R, Zoege T, Crowe RR (1998). Possible Association of a Cholecystokinin Promotor Polymorphism (CCK-36CT) With Panic Disorder. Am J Med Genet: Part B 81B:228-234.
41. Wei J, Hemmings GP (1999). The CCK-A receptor gene possibly associated with auditory hallucinations in schizophrenia. Eur Psychiatry 14:67-70.
42. Yamada K, Hattori E, Shimizu M, Sugaya A, Shibuya H, Yoshikawa T (2001). Association studies of the cholecystokinin B receptor and A2a adenosine receptor genes in panic disorder. J Neural Transm 108:837-848.
43. Zhang XY, Zhou DF, Zhang PY, Wei J (2000). The CCK-A receptor gene possibly associated with positive symptoms of schizophrenia. Mol Psychiatry 5:239-240.